{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:27:30Z","timestamp":1787502450653,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.intimp.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T05:09:43Z","timestamp":1527224983000},"page":"228-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["IL-9 exhibits elevated expression in osteonecrosis of femoral head patients and promotes cartilage degradation through activation of JAK-STAT signaling in vitro"],"prefix":"10.1016","volume":"60","author":[{"given":"Wei","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2018.05.005_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5312\/wjo.v3.i5.49","article-title":"Osteonecrosis of the femoral head: an update in year 2012","volume":"3","author":"Kaushik","year":"2012","journal-title":"World J. Orthop."},{"issue":"18","key":"10.1016\/j.intimp.2018.05.005_bb0010","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.85.18.6934","article-title":"Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity","volume":"85","author":"Uyttenhove","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2018.05.005_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00204898","article-title":"IL9 maps to mouse chromosome 13 and human chromosome 5","volume":"31","author":"Mock","year":"1990","journal-title":"Immunogenetics"},{"issue":"24","key":"10.1016\/j.intimp.2018.05.005_bb0020","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1073\/pnas.94.24.13175","article-title":"Interleukin 9: a candidate gene for asthma","volume":"94","author":"Nicolaides","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.intimp.2018.05.005_bb0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0171-2985(11)80414-6","article-title":"Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice","volume":"189","author":"Gessner","year":"1993","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4049\/jimmunol.1000356","article-title":"TGF-\u03b2 induces IL-9 production from human Th17 cells","volume":"185","author":"Beriou","year":"2010","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2018.05.005_bb0035","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4049\/jimmunol.165.4.1847","article-title":"Cytokine production and killer activity of NK\/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18","volume":"165","author":"Lauwerys","year":"2000","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2018.05.005_bb0040","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.4049\/jimmunol.164.11.5549","article-title":"Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1","volume":"164","author":"Stassen","year":"2000","journal-title":"J. Immunol."},{"issue":"7106","key":"10.1016\/j.intimp.2018.05.005_bb0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature05010","article-title":"Mast cells are essential intermediaries in regulatory T-cell tolerance","volume":"442","author":"Lu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2018.05.005_bb0050","series-title":"Advances in Immunology","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.ai.2014.09.004","article-title":"Group 2 innate lymphoid cells in the regulation of immune responses","author":"Roediger","year":"2015"},{"issue":"7","key":"10.1016\/j.intimp.2018.05.005_bb0055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.188.7.1307","article-title":"Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness","volume":"188","author":"Temann","year":"1998","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.12198","article-title":"Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis","volume":"175","author":"Ma","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"21","key":"10.1016\/j.intimp.2018.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/BRS.0000000000001621","article-title":"Interleukin-9 promotes TNF-\u03b1 and PGE2 release in human degenerated intervertebral disc tissues","volume":"41","author":"Zhang","year":"2016","journal-title":"Spine"},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0070","first-page":"28","article-title":"Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus","volume":"1","author":"Leng","year":"2012","journal-title":"Am. J. Clin. Experiment. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2018.05.005_bb0075","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.110268","article-title":"Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis","volume":"38","author":"Yanaba","year":"2011","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2018.05.005_bb0080","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/rheumatology\/kev252","article-title":"Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2018.05.005_bb0085","first-page":"37","article-title":"IL-9 signaling pathway: an update, Th9 Cells","author":"Roy","year":"2017","journal-title":"Met. Protocols"},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1302\/0301-620X.67B1.3155745","article-title":"Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment","volume":"67","author":"Ficat","year":"1985","journal-title":"J. Bone Joint Surg."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2010.09.095","article-title":"Analysis of isoform specific ERK signaling on the effects of interleukin-1\u03b2 on COX-2 expression and PGE2 production in human chondrocytes","volume":"402","author":"Wang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2018.05.005_bb0100","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2012-201505","article-title":"Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)","volume":"72","author":"Hughes-Austin","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2018.05.005_bb0105","doi-asserted-by":"crossref","first-page":"519638","DOI":"10.1155\/2015\/519638","article-title":"Increased serum interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: pathogenic role or just an epiphenomenon?","volume":"2015","author":"Dantas","year":"2015","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.intimp.2018.05.005_bb0110","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.1003049","article-title":"A brief history of IL-9","volume":"186","author":"Goswami","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2018.05.005_bb0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","article-title":"Th9 cells and il-9 in autoimmune disorders: pathogenesis and therapeutic potentials","volume":"78","author":"Deng","year":"2017","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxl117","article-title":"IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells","volume":"19","author":"Temann","year":"2006","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2018.05.005_bb0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.2105079","article-title":"Anti\u2013Interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model","volume":"166","author":"Cheng","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2018.05.005_bb0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2015.03.004","article-title":"IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: a plausible mechanism of IL-9R in atopic dermatitis","volume":"78","author":"Hong","year":"2015","journal-title":"J. Dermatol. Sci."},{"issue":"13","key":"10.1016\/j.intimp.2018.05.005_bb0135","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1084\/jem.20130071","article-title":"IL-9\u2013mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation","volume":"210","author":"Turner","year":"2013","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2018.05.005_bb0140","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.4373","article-title":"Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells","volume":"23","author":"Rauber","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2018.05.005_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/intimm\/7.1.115","article-title":"Sharing of the IL-2 receptor \u03b3 chain with the functional IL-9 receptor complex","volume":"7","author":"Kimura","year":"1995","journal-title":"Int. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918302169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T10:33:37Z","timestamp":1571394817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918302169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"alternative-id":["S1567576918302169"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.05.005","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-9 exhibits elevated expression in osteonecrosis of femoral head patients and promotes cartilage degradation through activation of JAK-STAT signaling in vitro","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}